No benefit of longer eradication therapy of Pseudomonas aeruginosa primoinfections in pediatric cystic fibrosis

被引:1
|
作者
Claude, F. [1 ]
Rochat, I. [2 ]
Hafen, G. M. [2 ]
机构
[1] Univ Lausanne, Fac Biol & Med, Lausanne, Switzerland
[2] CHU Vaudois, Dept Pediat, Resp Unit, Lausanne, Switzerland
关键词
Cystic fibrosis; Eradication protocol; Primoinfection; Pseudomonas aeruginosa;
D O I
10.1186/s13104-019-4157-8
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective: Patients with cystic fibrosis are more susceptible than members of the general population to lung infections. Infections with Pseudomonas aeruginosa require particular attention, because they may accelerate the deterioration of lung function if not adequately treated. This study assessed the eradication rate of P. aeruginosa primoinfections, with a protocol of inhaled tobramycin and oral ciprofloxacin over a 3 months' period. Results: Retrospective single-center study from June 1st, 2007 to December 31st, 2015. Inclusion of 28 pediatric patients (11 females, 17 males), with a total of 49 primoinfections. Overall success rate of 67.3%, which is similar or even inferior to figures published in the literature.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis
    Taccetti, G.
    Campana, S.
    Neri, A. S.
    Boni, V.
    Festini, F.
    [J]. JOURNAL OF CHEMOTHERAPY, 2008, 20 (02) : 166 - 169
  • [32] IMPACT OF SUCCESSFUL ERADICATION OF PSEUDOMONAS AERUGINOSA ON LONG TERM OUTCOMES IN CYSTIC FIBROSIS
    Hamblett, N. M.
    Rosenfeld, M.
    Kloster, M.
    Gibson, R.
    Retsch-Bogart, G. Z.
    Thompson, V.
    Ramsey, B.
    [J]. PEDIATRIC PULMONOLOGY, 2014, 49 : 317 - 317
  • [33] EVALUATION OF INHALED TOBRAMYCIN IN EARLY ERADICATION OF PSEUDOMONAS AERUGINOSA IN INFANTS WITH CYSTIC FIBROSIS
    Choi, J.
    Novak, K. J.
    Thompson, R.
    [J]. PEDIATRIC PULMONOLOGY, 2018, 53 : 275 - 275
  • [34] Factors influencing the acquisition and eradication of early Pseudomonas aeruginosa infection in cystic fibrosis
    Jackson, Lindsay
    Waters, Valerie
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (01) : 8 - 16
  • [35] Eradication of Pseudomonas aeruginosa in cystic fibrosis patients with inhalation of dry powder tobramycin
    Akkerman-Nijland, Anne M.
    Yousofi, Mina
    Rottier, Bart L.
    Van der Vaart, Hester
    Burgerhof, Johannes G. M.
    Frijlink, Henderik W.
    Touw, Daan J.
    Koppelman, Gerard H.
    Akkerman, Onno W.
    [J]. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2020, 14
  • [36] Aminoglycoside therapy against Pseudomonas aeruginosa in cystic fibrosis: A review
    Ratjen, Felix
    Brockhaus, Florian
    Angyalosi, Gerhild
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2009, 8 (06) : 361 - 369
  • [37] STAPHYLOCOCCUS AUREUS INTERACTION WITH NEWLY ACQUIRED PSEUDOMONAS AERUGINOSA FROM CYSTIC FIBROSIS PATIENTS UNDERGOING ERADICATION THERAPY
    Beaudoin, T.
    Baker, P.
    Yau, Y.
    Parsek, M.
    Hoffman, L.
    Howell, L.
    Waters, V. J.
    [J]. PEDIATRIC PULMONOLOGY, 2017, 52 : S349 - S349
  • [38] PSL-MEDIATED TOBRAMYCIN RESISTANCE IN PSEUDOMONAS AERUGINOSA ISOLATES FAILING ERADICATION THERAPY IN CHILDREN WITH CYSTIC FIBROSIS
    Uwumarenogie, S.
    Beaudoin, T.
    Yau, Y.
    Howell, L.
    Parsek, M. R.
    Hoffman, L.
    Nguyen, D.
    DiGiandomenico, A.
    Wozniak, D. J.
    Waters, V. J.
    [J]. PEDIATRIC PULMONOLOGY, 2019, 54 : S302 - S303
  • [39] EARLY PSEUDOMONAS AERUGINOSA TREATMENT AND LUNG FUNCTION IN PEDIATRIC CYSTIC FIBROSIS
    Casaredi, Gascon, I
    Klingel, M.
    Waters, V. J.
    Ratjen, F.
    [J]. PEDIATRIC PULMONOLOGY, 2019, 54 : S428 - S428
  • [40] Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic
    Armstrong, DS
    Nixon, GM
    Carzino, R
    Bigham, A
    Carlin, JB
    Robins-Browne, RM
    Grimwood, K
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (07) : 983 - 987